Archive | February, 2014

A Good Week For Rayno Life Science Stocks: AMRI, CBST, ILMN, RHHBY

Rayno Life Science Movers -Diagnostics Review Next Week Despite some choppiness in biotech trading this week many of our stocks did well. I won’t go into some of the unusual volatility in other small and mid-caps lately  but that is part of the reason for my “bubble” article. There is also a lot of focus […]

Continue Reading 0

Biotech Bull Market: OK Let’s Just Call It A Bubble

Biotech May Be A Bubble-But What to Do? The blogosphere is trying to temper bullish sentiment with a lot of “bubble “talk even though the cable channels are still pumping biotech.  If you have been around biotech for 25 years especially during the last true bubble -1999 -you should be a little skeptical of the […]

Continue Reading 0

Sierra SnowBlog: Good Storm Potential Next Week 2/26

Major Change in Weather Coming To West Coast By End of February Unisys Model Shows Breakdown of High Pressure Ridge by 2/27. Howard Sheckter sees MJO shift next weekend.A very technical discussion that means PPT! NOAA Shows an impressive low pressure front emerging next  week, with east Coast “polar express” moving out.Climate models from NOAA […]

Continue Reading 0

Rayno Life Science Stocks At New Highs-Another Look at 5 Key Trends (#3) Update 2/21

Update 2/21: Life Science stocks have blown through new highs this AM Large and mid-cap biopharma: ALKS  BIIB,PCYC,REGN SGEN etc ETFs: IBB ($270) and XBI ($165)  at new highs Two Rayno Dx laggard stocks on the move: RGDX and VRML. ———- Rayno Life Science Stocks Roll Merrily Along IBB ($264.50)At New Highs Up 16.4% YTD […]

Continue Reading 0

Stealth Sell-Off In Biotech Stocks

Profit Taking On High Fliers- INCY, MDVN, PBYI, XBI Agilent(A) Growth Slows NASDAQ Flat at 4234 12:15p EST After hitting new highs this week biotech stocks are in a wave of selling so watch technicals and volume.  The small cap, speculative weighted XBI ETF is down 1.81 % after an early reversal off AM Valentine’s Day […]

Continue Reading 0

Two Emerging Growth Biotechnology Stocks Hit $10B+ Valuations: INCY, PCYC

With Updates Today  2/13/14   XBI at $157.8 Biotechnology Bubblet- How High Can These Stocks Run? We reviewed mid-cap biopharmaceutical valuation in early October as part of our overall market model for a sector that defies classical analysis. Two emerging growth stocks in our model focused in oncology have soared to the $10B market cap […]

Continue Reading 0

Sierra SnowBlog: Wet and Wild Weekend With More Coming (?) in February Update 1

Update- 1   FEB 14 9:40a PST Back Peddling on Storm: usual High Pressure Ridge-Sheckter NOAA Shows Weakening Storm For Next Week Same for Unisys Model-Blocking High Intellicast 10 Day shows ppt diminishing ————– Pineapple Express Dumps on California Sierra skiing has been bailed out for February and with a little more help  from Hawaii […]

Continue Reading 0

Large Cap Biopharmaceuticals -Valuations and Earnings Potential

 Large Cap Biotechs Hover Near January 2014 Highs IBB At $254 on 2/11/14 The biotechnology sector has come roaring back after a 5-7% correction in February. Only one stock is at a new high Alexion (ALXN $171) . Many speculative mid and small caps are doing slightly better if we look at the proxy ETF […]

Continue Reading 0

Snap-Back Rally in Biotech Up 4+% Friday

Life Science Stocks Surge Ahead From February Lows  NASDAQ Up 1.67%, IBB Up 4%, FBIOX up 4.72%, XBI up 5.64%, XLV up 1.7% The soaring biotech sector would not let a losing week go by and took off early Friday erasing most losses for the week 2/3 to 2/7. Institutions can apparently drive biotech stocks […]

Continue Reading 0

Biotech Bull Market Up 6%+YTD: Key Trends to Watch Update #2

Biotech Bull Market Intact But Technicals Rule On January 27 we reiterated our model for life science stocks for 2014. We will review each component of our model and where the sector stands after about a 5% correction off highs with the sector still up 6% YTD depending on the index, fund or ETF (IBB). […]

Continue Reading 0